Showing results (1-10 of 176) with videos related to

Sort By:
Pageof 18
Advances in Experimental Medicine and Biology|May 16, 2022
ABCA1, ABCG1, and Cholesterol HomeostasisXiao-Hua Yu, Chao-Ke Tang
Advances in Clinical Chemistry|September 29, 2015
Peroxisome Proliferator-Activated Receptor α in Lipid Metabolism and AtherosclerosisXiao-Hua Yu, Xi-Long Zheng, Chao-Ke Tang
Advances in Clinical Chemistry|August 2, 2015
Nuclear Factor-κB Activation as a Pathological Mechanism of Lipid Metabolism and AtherosclerosisXiao-Hua Yu, Xi-Long Zheng, Chao-Ke Tang
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 31, 2019
CXC chemokine ligand 12 (CXCL12) in atherosclerosis: An underlying therapeutic targetJia-Hui Gao, Xiao-Hua Yu, Chao-Ke Tang
Cytokine|February 22, 2023
CTRP1: A novel player in cardiovascular and metabolic diseasesYang Wang, Heng Li, Xiao-Hua Yu, et al.
Journal of Cellular Physiology|December 4, 2020
Zinc finger E-box binding homeobox 1 and atherosclerosis: New insights and therapeutic potentialHeng Li, Jin Zou, Xiao-Hua Yu, et al.
Immunology and Cell Biology|November 15, 2018
Itaconate: an emerging determinant of inflammation in activated macrophagesXiao-Hua Yu, Da-Wei Zhang, Xi-Long Zheng, et al.
Atherosclerosis|July 30, 2018
C1q tumor necrosis factor-related protein 9 in atherosclerosis: Mechanistic insights and therapeutic potentialXiao-Hua Yu, Da-Wei Zhang, Xi-Long Zheng, et al.
Progress in Lipid Research|December 12, 2018
Cholesterol transport system: An integrated cholesterol transport model involved in atherosclerosisXiao-Hua Yu, Da-Wei Zhang, Xi-Long Zheng, et al.
Progress in Lipid Research|June 7, 2021
Hepatic cholesterol transport and its role in non-alcoholic fatty liver disease and atherosclerosisHeng Li, Xiao-Hua Yu, Xiang Ou, et al.
Pageof 18